SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-060045
Filing Date
2024-05-15
Accepted
2024-05-15 07:53:29
Documents
57
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q caba-20240331.htm   iXBRL 10-Q 1965110
2 EX-10.1 caba-ex10_1.htm EX-10.1 75506
3 EX-31.1 caba-ex31_1.htm EX-31.1 16254
4 EX-31.2 caba-ex31_2.htm EX-31.2 16231
5 EX-32.1 caba-ex32_1.htm EX-32.1 9268
6 EX-32.2 caba-ex32_2.htm EX-32.2 9777
  Complete submission text file 0000950170-24-060045.txt   7020152

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20240331.xsd EX-101.SCH 909941
61 EXTRACTED XBRL INSTANCE DOCUMENT caba-20240331_htm.xml XML 1082507
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 24947211
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)